The increasing role of <scp>PDE5Is</scp> in men with diabetes and cardiovascular disease

Diabetes is strongly associated with erectile dysfunction, which itself a risk factor for cardiovascular events and mortality. Evidence shows that phosphodiesterase type 5 inhibitor (PDE5I) use in men 2 diabetes mellitus significant reduction all-cause mortality morbidity. Despite the evidence, PDE5Is appear to be underused this male cohort.